Preserving venous function with hemodynamics-based treatment, led by Dr. Zhang Qiang's Medical Group
CHIVA (Cure Conservatrice et Hémodynamique de l'Insuffisance Veineuse en Ambulatoire) was developed by French surgeon Prof. Claude Franceschi in 1988. It is a hemodynamic approach that precisely locates reflux sources and restructures blood flow using minimally invasive techniques while preserving venous function.
Unlike traditional destructive surgeries that remove veins, CHIVA preserves the venous structure, maintaining physiological function. This approach reduces recurrence rates to less than 1% while providing excellent long-term outcomes.
Back to Therapies Contact UsCHIVA is suitable for patients at various stages with different needs
Covers C2-C6 stages. Particularly suitable for patients who wish to preserve venous function and pursue minimally invasive recovery.
Precisely locate reflux points, minimally invasive correction of blood flow, preserving veins for future cardiovascular surgery needs.
Local anesthesia with minimal trauma. Suitable for elderly patients and those with diabetes, hypertension, or other conditions who cannot tolerate traditional surgery.
Significantly lower 10-year recurrence rate than traditional surgery. Even if recurrence occurs, secondary treatment involves minimal trauma and quick recovery.
CHIVA represents the advancement of precision, minimally invasive, and function-preserving treatment
Preoperative Doppler ultrasound precisely evaluates hemodynamics, locating lesions to develop personalized treatment plans.
Local anesthesia only. Incisions just a few millimeters. Patients discharged within 1 hour. Preserves core venous structures.
Correcting blood flow abnormalities at the source results in extremely low recurrence and complication rates. No need for long-term compression stockings.
Same-day surgery and discharge. Shorter medical cycles without hospitalization. Ideal for busy professionals.
China's first specialist doctor group focusing on venous disease diagnosis and treatment. Also the pioneer and standardized promotion benchmark for CHIVA technology worldwide.
Hosted the 2019 International Venous Disease Forum, published Asia's first CHIVA consensus
First overseas CHIVA center in Africa (2023), US operations launched (2024), New York HQ (2025)
Partnering with INTELEOS for global CHIVA certification program
Contact us to learn if CHIVA is suitable for your condition
Consult Now